All Biologics Content

Bringing you the latest research in Proteins and Antibodies, Peptides, and Oligonucleotides through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Insight Article
Key opinion leaders share their thoughts on the prospect of effector cell redirection and cell engagers at Biologics UK: In-Person 2022.
Edited by Tia Byer |
07 June 2022
Bispecifics
Insight Article
Stimulating T cells using bispecific antibody immunotherapies can lead to transformational clinical benefits for cancer patients. So how exactly is the industry addressing the need for targeted T cell-based immunotherapies?
Edited by Tia Byer |
28 February 2022
Bispecifics
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our November Discussion Group addressing ‘Bi-and Multi-Specific Antibodies - Formats, Applications, and Paths to the Clinic’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
Edited by Tia Byer |
09 February 2022
Bispecifics
Commentary
The joint development project by Alligator Bioscience and Aptevo Therapeutics, ALG.APV-527, shows potential in targeting solid tumours
Edited by Tom Cohen |
17 January 2022
Bispecifics
Video Content
Video Q&A
Video Interview: Find out why Neo-X is so unique
22 February 2021
Bispecifics
Video Content
Video Q&A
Video Interview: Let's talk bispecific antibodies. 10 minutes with... Bryan Glaser, Vice President of Invenra
10 February 2021
Bispecifics
Video Content
Webinar
Workshop Speakers Include: Christian Klein, Department Head Cancer Immunotherapy Discovery 3, Roche Innovation Center Zurich | Julian Andreev, Research Fellow, Regeneron | Marlon Hinner, Principal Scientist & Group Leader, Roche Innovation Centre Munich | Danielle Mandikan, Scientist, Genentech
07 July 2020
Bispecifics
Written Q&A
John Delaney, Director, Research Technologies and Collaborations, Amgen. Date of Congress: 27th - 29th April 2020
02 January 2020
Bispecifics
Video Content
Webinar
Webinar on 'Bispecific Antibodies Targeting The Innate Immune Checkpoint CD47'Hosted by Nicolas Fischer, Chief Executive Officer, Light Chain Bioscience
02 January 2020
Bispecifics
Written Q&A
Antonin De Fougerolles, Chief Executive Officer, Evox Therapeutics
11 June 2019
Bispecifics

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login